+ All Categories
Home > Healthcare > Results from Canadian SSI Prevention Audit

Results from Canadian SSI Prevention Audit

Date post: 17-Jan-2017
Category:
Upload: canadian-patient-safety-institute
View: 732 times
Download: 0 times
Share this document with a friend
60
2016 CANADIAN SURGICAL SITE INFECTION PREVENTION AUDIT Dr. Claude Laflamme March 24, 2016
Transcript

2016 CANADIAN SURGICAL SITE INFECTION

PREVENTION AUDIT Dr. Claude Laflamme

March 24, 2016

Welcome! Bienvenue à nos participants francophones Hélène Riverin

Carla Williams Patient Safety Improvement Lead

Please enter any questions in the chat box Today’s slides This call will be taped

Before we get started

- AHS-Surgery Strategic Clinical Network; Stacy Kozak

- Atlantic Health Quality & Patient Safety Collaborative; Amy Howard - BC Patient Safety & Quality Council; Geoff Schierbeck - Health Quality Ontario; Mina Viscardi-Johnson - Sask. Ministry of Health- Patient Safety Unit; Jocelyn Leblond

Thank you!

Patient Safety Metrics Team: - Virginia Flintoft - Alex Titeu - Anne MacLaurin - CPSI Dr. Curt Smecher Dr. Claude Laflamme

Our Guest Speakers

Audit Participation SSI Prevention Results

SSI Scores Summary

Audit Participation

Sites 52

Patients 2082

Clean I & II 1998

Responses by Province

SSI Prevention Audit

Cardiac OnPump /

Chirurgiecardiaque avec

pompe

Cardiac OffPump /

Chirurgiecardiaque sans

pompe

C-Section /Césarienne

GeneralSurgery /Chirurgiegénérale

Gynecology /Chirurgie

gynécologique

Ophthalmology/ Chirurgie

ophtalmologi..

Orthopedics /Orthopédique

Vascular /Chirurgievasculaire

Thoracic /Chirurgie

thoracique

Other / Autre No Response /Pas de

réponse

0%

10%

20%

30%

40%

50%

Re

239

298

570

211

501

6336

2052

71

29%

SitesPatients 1,998

52

Participants by Type of Surgery

SSI Prevention Audit

Participants by Surgical Wound Class

Sites 52 Patients 2082

Participants by Surgical Wound Class I and II

Audit Participation SSI Prevention Results

SSI Scores Summary

How to interpret the indicator slides

Sites/Patients = Total counts Green bar = Best Practice Red Bar = Incorrect Practice Grey Bar = Not Recorded or No

Response Y-Axis = % Total Records - Green

+ Red + Grey bars (e.g. % overall Best Practice = 60%)

n = 900 Sum of green and red bar counts Green Bubble = Best Practice /

(Best + Incorrect Practice) x 100 Red Bubble = Incorrect Practice /

(Best + Incorrect Practice) x 100

67%

33%

Sites 52 Patients 1000 n = 900

SSI Prevention Audit

C. Pre-op shower or bath with soap or antiseptic agent

Not Recorded = 781

n = 1209

85%

15%

C. Pre-op shower or bath with soap or antiseptic agent

Total Patients 867

81% 88%

88%

66%

n = 354 n = 338 n = 131 n = 74

SSI Prevention Audit

D. Solution used for intra-operative intact skin cleansing

Sites 52 Patients 1998

Note: Yes includes • 2% CHD w alc, P-I with alc & Contraindicated for all • PI for Gyne and C-Section • PI Head and Neck for Ophthalmology and Other.

n = 1959

74%

26%

Sites 52 Patients 1998

D. Solution used for intra-operative intact skin cleansing

68% 82% 92% 88%

Total Patients 1487

n = 558 n = 500 n = 230 n = 173

Note: Yes includes • 2% CHD w alc, P-I with alc & Contraindicated for all • PI for Gyne and C-Section.

SSI Prevention Audit

Antibiotics not indicated / Antibiotiques non indiqués,Within 120 minutes before incision for Vancomycin orFluoroquinolones / Dans les 120 minutes précédantl’incision, dans le cas de la vancomycine ou de la

fluoroquinolone, Within 60 minutes before incision /Dans les 60 minutes précédant l’incision chirurgicale

No antibiotics given / Aucun antibiotique n’a étéadministré & None of the above / Aucun de ces choix

No Response / Pas de réponse & Not Recorded / Nonconsigné

0%

20%

40%

60%

80%

100%

Re

1,779

178

41

E. Prophylactic Abx administration

Sites 52 Patients 1998

n = 1957

91%

9%

General Surgery / Chirurgiegénérale Orthopedics / Orthopédique

Gynecology / Chirurgiegynécologique C-Section / Césarienne

Antibiotics notindicated /

Antibiotiquesnon indiqués,

Within 120minutes before

incision forVancomycin orFluoroquinolo..

No antibioticsgiven / Aucunantibiotique

n’a étéadministré &None of the

above / Aucunde ces choix

No Response /Pas de

réponse & NotRecorded /

Non consigné

Antibiotics notindicated /

Antibiotiquesnon indiqués,

Within 120minutes before

incision forVancomycin orFluoroquinolo..

No antibioticsgiven / Aucunantibiotique

n’a étéadministré &None of the

above / Aucunde ces choix

No Response /Pas de

réponse & NotRecorded /

Non consigné

Antibiotics notindicated /

Antibiotiquesnon indiqués,

Within 120minutes before

incision forVancomycin orFluoroquinolo..

No antibioticsgiven / Aucunantibiotique

n’a étéadministré &None of the

above / Aucunde ces choix

No Response /Pas de

réponse & NotRecorded /

Non consigné

Antibiotics notindicated /

Antibiotiquesnon indiqués,

Within 120minutes before

incision forVancomycin orFluoroquinolo..

No antibioticsgiven / Aucunantibiotique

n’a étéadministré &None of the

above / Aucunde ces choix

No Response /Pas de

réponse & NotRecorded /

Non consigné

0%

20%

40%

60%

80%

100%

Re

481

75

14

478

16 7

214

24

1

180

15 16

E. Prophylactic Abx administration Total Patients 1521

87% 97% 90% 92%

n = 556 n = 494 n = 238 n = 195

SSI Prevention Audit

1g < 80kg, 2g < 80kg, 2g > 120kg, 2g 80-120 kg, 3g >=120kg & Weight based dose for paediatric patient /

Posologie en fonction du poids pour les patients enpédiatrie

< 1g for any adult patient / pour tout patient adulte, > 3g,1g >= 80kg, 3g >= 120kg,

No antibiotics given / Aucun antibiotique administré &Other antibiotic used / Autre antibiotique

No Response / Pas de réponse & Not Recorded / Nonconsigné

0%

20%

40%

60%

80%

100%

Re 1,274

636

88

F. Dose of Cefazolin used as Prophylactic Abx

Sites 52 Patients 1998 n = 1910

67%

33%

General Surgery / Chirurgiegénérale Orthopedics / Orthopédique

Gynecology / Chirurgiegynécologique C-Section / Césarienne

1g < 80kg, 2g <80kg, 2g > 120kg,2g 80-120 kg, 3g

>= 120kg &Weight based

dose forpaediatric patient

/ Posologie enfonction du poidspour les patients

en pédiatrie

< 1g for any adultpatient / pour toutpatient adulte, >3g, 1g >= 80kg,

3g >= 120kg, No antibioticsgiven / Aucunantibiotiqueadministré &

Other antibioticused / Autreantibiotique

No Response /Pas de réponse &

Not Recorded /Non consigné

1g < 80kg, 2g <80kg, 2g > 120kg,2g 80-120 kg, 3g

>= 120kg &Weight based

dose forpaediatric patient

/ Posologie enfonction du poidspour les patients

en pédiatrie

< 1g for any adultpatient / pour toutpatient adulte, >3g, 1g >= 80kg,

3g >= 120kg, No antibioticsgiven / Aucunantibiotiqueadministré &

Other antibioticused / Autreantibiotique

No Response /Pas de réponse &

Not Recorded /Non consigné

1g < 80kg, 2g <80kg, 2g > 120kg,2g 80-120 kg, 3g

>= 120kg &Weight based

dose forpaediatric patient

/ Posologie enfonction du poidspour les patients

en pédiatrie

< 1g for any adultpatient / pour toutpatient adulte, >3g, 1g >= 80kg,

3g >= 120kg, No antibioticsgiven / Aucunantibiotiqueadministré &

Other antibioticused / Autreantibiotique

No Response /Pas de réponse &

Not Recorded /Non consigné

1g < 80kg, 2g <80kg, 2g > 120kg,2g 80-120 kg, 3g

>= 120kg &Weight based

dose forpaediatric patient

/ Posologie enfonction du poidspour les patients

en pédiatrie

< 1g for any adultpatient / pour toutpatient adulte, >3g, 1g >= 80kg,

3g >= 120kg, No antibioticsgiven / Aucunantibiotiqueadministré &

Other antibioticused / Autreantibiotique

No Response /Pas de réponse &

Not Recorded /Non consigné

0%

20%

40%

60%

80%

100%

Re 328

220

22

413

4939

145

89

5

146

54

11

F. Dose of Cefazolin used as Prophylactic Abx

Total Patients 1521

60% 89% 62% 73%

n = 548 n = 462 n = 234 n = 200

SSI Prevention Audit

Yes / Oui & Redosing not required / Redosage nonrequis

No / Non No Response / Pas de réponse, No prophylacticantibiotic given / Aucune antibioprophylaxieadministrée, Not Recorded / Non consigné

0%

20%

40%

60%

80%

100%

Re

1,490

46 46

G. Appropriate Prophylactic Antibiotic Redosing according to guidelines

Sites 52 Patients 1582

97%

3%

n = 1536

General Surgery / Chirurgie générale Orthopedics / Orthopédique Gynecology / Chirurgie gynécologique C-Section / Césarienne

Yes / Oui &Redosing not

required /Redosage no..

No / Non No Response /Pas de

réponse, Noprophylactic a..

Yes / Oui &Redosing not

required /Redosage no..

No / Non No Response /Pas de

réponse, Noprophylactic a..

Yes / Oui &Redosing not

required /Redosage no..

No / Non No Response /Pas de

réponse, Noprophylactic a..

Yes / Oui &Redosing not

required /Redosage no..

No Response /Pas de

réponse, Noprophylactic a..

0%

20%

40%

60%

80%

100%

Re

376

1913

463

3 7

168

2 2

170

10

G. Appropriate Prophylactic Antibiotic Redosing according to guidelines

Total Patients 1233

97% 99% 99% 100%

n = 389 n = 466 n = 170 n = 170

G. Appropriate Prophylactic Antibiotic Redosing according to guidelines (Yes/No)

Total Patients 227

80%

20%

SSI Prevention Audit

H. Discontinuation of Prophylactic Abx

Sites 52 Patients 1998 n = 1905

80%

20%

General Surgery / Chirurgiegénérale Orthopedics / Orthopédique

Gynecology / Chirurgiegynécologique C-Section / Césarienne

ABX discontinuedwithin 24 hours ofend of surgery /

L’administration desantibiotiques a

cessé dans les 24heures suivant la fin

de la chirurgie &ABX not received

after end of surgery/ Aucun antibiotiqueadministré après la..

ABX discontinuedmore than 24 hoursafter end of surgery

/ L’administrationdes antibiotiques acessé plus de 24

heures après la finde la chirurgie & No

antibiotics given /Aucun antibiotiquen’a été administré

No Response / Pasde réponse & NotRecorded / Non

consigné

ABX discontinuedwithin 24 hours ofend of surgery /

L’administration desantibiotiques a

cessé dans les 24heures suivant la fin

de la chirurgie &ABX not received

after end of surgery/ Aucun antibiotiqueadministré après la..

ABX discontinuedmore than 24 hoursafter end of surgery

/ L’administrationdes antibiotiques acessé plus de 24

heures après la finde la chirurgie & No

antibiotics given /Aucun antibiotiquen’a été administré

No Response / Pasde réponse & NotRecorded / Non

consigné

ABX discontinuedwithin 24 hours ofend of surgery /

L’administration desantibiotiques a

cessé dans les 24heures suivant la fin

de la chirurgie &ABX not received

after end of surgery/ Aucun antibiotiqueadministré après la..

ABX discontinuedmore than 24 hoursafter end of surgery

/ L’administrationdes antibiotiques acessé plus de 24

heures après la finde la chirurgie & No

antibiotics given /Aucun antibiotiquen’a été administré

No Response / Pasde réponse & NotRecorded / Non

consigné

ABX discontinuedwithin 24 hours ofend of surgery /

L’administration desantibiotiques a

cessé dans les 24heures suivant la fin

de la chirurgie &ABX not received

after end of surgery/ Aucun antibiotiqueadministré après la..

ABX discontinuedmore than 24 hoursafter end of surgery

/ L’administrationdes antibiotiques acessé plus de 24

heures après la finde la chirurgie & No

antibiotics given /Aucun antibiotiquen’a été administré

No Response / Pasde réponse & NotRecorded / Non

consigné

0%

20%

40%

60%

80%

100%

Re 433

88

49

417

10

74

170

13

56

202

36

H. Discontinuation of Prophylactic Abx Total Patients 1521

83% 85% 75% 97%

n = 521 n = 491 n = 226 n = 208

SSI Prevention Audit

Clippers / Tondeuse, Depilatory / Dépilatoire, Hairremoval not required / Épilation non requise

Razor / Rasoir & Removal done at home / Épilationeffectuée à la maison

No Response / Pas de réponse & Not Recorded / Nonconsigné

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Re

1,743

182

73

I. Hair Removal Method

Sites 52 Patients 1998

96%

4%

n = 1816

Not Recorded = 15

General Surgery / Chirurgie généraleOrthopedics /Orthopédique Gynecology / Chirurgie gynécologique C-Section / Césarienne

Clippers /Tondeuse,Depilatory /

Dépilatoire, Hairremoval notrequired /

Épilation nonrequise

Razor / Rasoir& Removal

done at home /Épilation

effectuée à lamaison

No Response /Pas de réponse& Not Recorded/ Non consigné

Clippers /Tondeuse,Depilatory /

Dépilatoire, Hairremoval notrequired /

Épilation nonrequise

No Response /Pas de réponse& Not Recorded/ Non consigné

Clippers /Tondeuse,Depilatory /

Dépilatoire, Hairremoval notrequired /

Épilation nonrequise

Razor / Rasoir& Removal

done at home /Épilation

effectuée à lamaison

No Response /Pas de réponse& Not Recorded/ Non consigné

Clippers /Tondeuse,Depilatory /

Dépilatoire, Hairremoval notrequired /

Épilation nonrequise

Razor / Rasoir& Removal

done at home /Épilation

effectuée à lamaison

No Response /Pas de réponse& Not Recorded/ Non consigné

0%

20%

40%

60%

80%

100%

Re

517

1736

468

33

209

1812

134

13

64

I. Hair Removal Method Total Patients 1521

97% 100% 92% 91%

n = 534 n = 468 n = 227 n = 147

SSI Prevention Audit

J. Glucose was below 11.1 mmol/L on each of POD 0, 1 and 2

Sites 34 Patients 474

Note: Not at Risk (not diabetic) excluded from this measure (n=1513)

n = 390

57%

43%

Not Recorded = 7

General Surgery / Chirurgiegénérale Orthopedics / Orthopédique

Gynecology / Chirurgiegynécologique C-Section / Césarienne

Yes / Oui Gluc. NotDone /

Glycémie nontestée & No /

Non

No Response /Pas de

réponse & NotRecorded /

Non consigné

Yes / Oui Gluc. NotDone /

Glycémie nontestée & No /

Non

No Response /Pas de

réponse & NotRecorded /

Non consigné

Yes / Oui Gluc. NotDone /

Glycémie nontestée & No /

Non

No Response /Pas de

réponse & NotRecorded /

Non consigné

Yes / Oui Gluc. NotDone /

Glycémie nontestée & No /

Non

No Response /Pas de

réponse & NotRecorded /

Non consigné

0%

20%

40%

60%

80%

100%

Re

49

28

62

48

93

5

13

10

21

16

6

4

J. Glucose was below 11.1 mmol/L on each of POD 0, 1 and 2

Total Patients 355

56%

66%

32% 60%

Note: Not at Risk (not diabetic) excluded from this measure

n = 111 n = 141 n = 31 n = 10

SSI Prevention Audit

Induced Hypothermia / Hypothermie induite & Yes / Oui No / Non No Response / Pas de réponse & Not Recorded / Nonconsigné

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Re

1,329

435

234

K. Temperature at end of surgery or on arrival in PACU - 36.0 - 38.0 degrees C

Sites 52 Patients 1998 n = 1563

85%

15%

Not Recorded = 100

General Surgery / Chirurgiegénérale Orthopedics / Orthopédique

Gynecology / Chirurgiegynécologique C-Section / Césarienne

InducedHypothermia /Hypothermie

induite & Yes /Oui

No / Non No Response /Pas de

réponse & NotRecorded /

Non consigné

InducedHypothermia /Hypothermie

induite & Yes /Oui

No / Non No Response /Pas de

réponse & NotRecorded /

Non consigné

InducedHypothermia /Hypothermie

induite & Yes /Oui

No / Non No Response /Pas de

réponse & NotRecorded /

Non consigné

InducedHypothermia /Hypothermie

induite & Yes /Oui

No / Non No Response /Pas de

réponse & NotRecorded /

Non consigné

0%

20%

40%

60%

80%

100%

Re

394

84 92

285

180

36

158

3942

136

25

50

K. Temperature at end of surgery or on arrival in PACU - 36.0 - 38.0 degrees C

Total Patients 1521

82%

89%

79% 84%

n = 478 n = 321 n = 200 n = 161

% Not Recorded by Indicator

Audit Participation SSI Prevention Results

SSI Scores Summary

SSI Scores – % Perfect Performance Total Patients 1998

Pre-op SSI Score by Province % Perfect Performance

Total Patients 1998

Peri-op SSI Score by Province % Perfect Performance

Total Patients 1998

Post-op SSI Score by Province % Perfect Performance

Total Patients 1998

Overall SSI Score by Province % Perfect Performance

Total Patients 1998

Audit Participation SSI Prevention Results

SSI Scores Summary

Orthopedics – consistent high performers Ontario – 18 sites and 863 patients Nova Scotia – 8 sites and 477 patients

• Colchester East Hants submitting monthly since July ‘15

Yukon – 1 site & 132 patients: 1st National audit participation!

Summary

Limitations of a bundle of care Culture of Patient Safety Opportunities for Improvement

– High ‘Not Recorded’ rate – especially in Pre-op shower or bath with soap or antiseptic agent

– (F.) Dose of Cefazolin used as Prophylactic Abx – (J.) Glucose was below 11.1 mmol/L on each of POD 0, 1 & 2 – (K.) Temperature at end of surgery or on arrival in PACU -

36.0oC to 38.0oC

Summary

Continue with your improvement work (95%) Opportunities for learning

– New Centers for Disease Control (CDC) report

Topic for Next National Call Glucose Control (date tba)

Next Steps

Access your data and reports at any time in Patient Safety Metrics – Surgical Site Infection Pre-operative (Pre-op) Score (SSI 14) – Surgical Site Infection Perioperative Score (SSI 15) – Surgical Site Infection Postoperative (Post-op) Score (SSI 16) – Surgical Site Infection Score (SSI 17) – https://psmetrics.utoronto.ca/metrics/login.aspx

Overall organization results – ‘Report’ tab > ‘SSI’ sub-tab

Individual unit results – ‘Data’ tab > ‘SSI’ intervention > ‘Measurement Worksheet’

table

Your Results and Scores

The Surgical Safety Checklist; More Than Just a “Good Catch” April 8th- 12:00 est Guests: Stacy Kozak Leslie Deuchar

FYI…

For Audit forms and Data Questions CPSI Central Measurement Team [email protected] Virginia Flintoft (416) 946-8350 Alexandru Titeu (416) 946-3103 For SSI intervention related questions: Carla Williams [email protected] (709) 685-8254

Contacts


Recommended